Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Pierre Fabre Pharma Norden AB

Closing information (x1000 EUR)

Closing information 2022/12 2021/12 2020/12
Turnover 21,828 Less Arrow 20,320 Less Arrow 18,639
Financial expenses 52 Less Arrow 28 More Arrow 57
Earnings before taxes 724 Less Arrow 567 More Arrow 696
EBITDA 796 Less Arrow 604 More Arrow 764
Total assets 11,710 More Arrow 14,207 Less Arrow 13,616
Current assets 11,627 More Arrow 14,104 Less Arrow 13,503
Current liabilities 9,440 More Arrow 12,285 Less Arrow 9,698
Equity capital 2,270 Less Arrow 1,922 More Arrow 2,423
- share capital 36 More Arrow 39 More Arrow 40
Employees (average) 15 Less Arrow 14 Less Arrow 13

Financial ratios

Fiscal year 2022/12 2021/12 2020/12
Solvency 19.4% Less Arrow 13.5% More Arrow 17.8%
Turnover per employee 1,455 Less Arrow 1,451 Less Arrow 1,434
Profit as a percentage of turnover 3.3% Less Arrow 2.8% More Arrow 3.7%
Return on assets (ROA) 6.6% Less Arrow 4.2% More Arrow 5.5%
Current ratio 123.2% Less Arrow 114.8% More Arrow 139.2%
Return on equity (ROE) 31.9% Less Arrow 29.5% Less Arrow 28.7%
Change turnover 3,155 Less Arrow 2,026 More Arrow 2,851
Change turnover % 17% Less Arrow 11% More Arrow 18%
Chg. No. of employees 1 Equal arrow 1 Less Arrow -3
Chg. No. of employees % 7% More Arrow 8% Less Arrow -19%

Total value of public sale

Fiscal year 2022/12 2021/12 2020/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.